CD200 expression marks leukemia stem cell (LSC) in human AML
收藏官方服务：
资源简介：
This SuperSeries is composed of the SubSeries listed below.
应用场景：
创建时间：
2022-02-20
相关数据集
The H3K4-methyl epigenome regulates MLL leukemia stem cell oncogenic potential
The genetic programs that maintain leukemia stem cell (LSC) self-renewal and oncogenic potential have been well defined, however the epigenetic landscape that determines their cellular identity and fu
NIAID Data Ecosystem80
NRASG12V mediates leukemia self renewal [RNA-Seq]
Mutant RAS oncoproteins activate signaling molecules that drive oncogenesis in multiple human tumors including acute myelogenous leukemia (AML). However, the specific function of these pathways in AML
NIAID Data Ecosystem50
A Leukemic Stem Cell Expression Signature is Associated with Clinical Outcomes in Acute Myeloid Leukemia
Context: In many cancers, specific subpopulations of cells appear to be uniquely capable of initiating and maintaining tumors. The strongest support for this cancer stem cell model comes from transpla
NIAID Data Ecosystem40
Epigenetic mechanisms controlling human leukemia stem cells and therapy resistance [RNA-seq]
Many human cancers, including acute myeloid leukemia (AML), arise from mutations of stem and progenitor cells. Immunophenotypic profiling has shown that leukemia develops hierarchically, with mutation
NIAID Data Ecosystem60
Loss of PRMT7 reprograms glycine metabolism selectively eradicating leukemia stem cells in CML
Selective elimination of cancer stem-like cells (CSCs) but not normal stem cell counterparts may offer potential for curative therapies in certain types of cancer. Chronic myeloid leukemia (CML) is a
NIAID Data Ecosystem40
